New antiviral COVID-19 treatments are coming but getting enough supply to fight the omicron variant surge is a concern.
Author: Karen Weintraub, USA TODAY
Could treatments for rare diseases be found in neighborhood pharmacies? New uses for old drugs offer promise
For patients with extremely rare diseases, repurposing existing drugs may be their only hope.
A year after first COVID-19 vaccine, here’s what’s next for researchers – and what worries them
A year after the first COVID-19 vaccines were administered in the U.S., what do researchers have their sights set on? Perhaps, a future without shots.
Where did the coronavirus omicron variant come from? Science suggests it evolved in one person.
The omicron variant of the coronavirus may have first developed in a single immunocompromised person.
FDA panel narrowly recommends authorization of first antiviral to treat COVID-19
The drug, molnupiravir from Merck, is intended to be used in people at risk for severe COVID-19. The FDA panel authorized its use by a vote of 13-10.
COVID booster shots are now recommended for all American adults: What you should know
Vaccine experts say there’s little down side to getting a COVID vaccine booster dose. Side effects are comparable to the initial round of shots.
COVID vaccines for kids aren’t as clear-cut as for adults: 5 factors for parents to consider
The Pfizer-BioNTech COVID vaccine could become available for children ages 5 to 11 as soon as next week. Here’s what we know, and don’t know.
Do you need another shot? Can you mix and match vaccines? COVID booster questions, answered.
COVID-19 boosters are expected to become widely available in the coming days and everyone eligible will be able to choose their preferred vaccine.
Natural immunity is good. Getting vaccinated after being sick with COVID-19 is better.
A growing body of research suggests previous coronavirus infection plus vaccination provides the strongest protection against COVID-19.
New treatments offer hope with vaccines for ‘interlocking benefits’ against COVID-19
COVID-19 vaccines offer the best protection against severe illness and death, but new antibody and antiviral treatments offer “interlocking benefits.”